3Daniel D, Von Hoff M D, Danomycin- induuced cardiotoxicity in children and adults a reiview of 110 case.The American Journal of Medicine. 1997 ; 62 : 200 - 208.
1[1]Lefrak E A, Pitha J. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer,1973,32: 302-314.
2[2]Daniel D, Von Hoff M D.Danomycin-induced cardiotoxicity in children and adults a reiview of 110 cases. The American Journal of Medicine,1977,62:200-208.
3[3]Cindy L S, Windy L H.Correted QT interval prolongation in anthacycline-treated survivors of childhood cancer. Journal of Clinical Oncology,1993,11:1906-1910.
4[4]Karen S B, Jon P S.QT interval prolongation associated with anthracycline cardiotoxicity. The Journal of Pediartrics,1984,105: 442-444.
5[5]Schwartz P J, Perti M.The long QT syndrome. Am Heart J, 1975,89: 378-390.
6[6]Wortman J E, Lucas V S.Sudden death during doxorubicin administration. Cancer,1979, 44: 1588-1590.
7[7]Regina I J, Ranae L L.Comparison of cardiac function tests after anthracycline therapy in childhood: implications for screening. Cancer,1993, 72: 2739-2745.
5Jimenez R E, Zalupski M M, Frank J J, et al. Multidrug resistance phenotype: In high grade soft tissue sarcoma [J]. Cancer, 1999, 86: 976-981.
6Naater K, Stater G. Molecular Mechanisms of Multidrug Resistance in Cancer Chemotherapy [J]. Path Res Pract, 1996, 192: 768-780.
7周洪玉.生脉注射液药效物质基础研究[D].长春:吉林大学,2011.
8Kalivendi S V, Kotamraju S, Zhao H T, et al. Doxorubicin-induced apoptosis is associated with increased transcription of endothelial nitric-oxide synthase [J]. Biol Chem, 2001, 276(50): 47266-47276.
